Chapter/Section Purchase

1 Study Coverage
1.1 Oncology Generic Injectable Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Generic Injectable Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Market by Application
1.3.1 Global Oncology Generic Injectable Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Generic Injectable Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology Generic Injectable Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology Generic Injectable Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology Generic Injectable Drugs Sales by Region
2.4.1 Global Oncology Generic Injectable Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Oncology Generic Injectable Drugs by Region (2023-2028)
2.5 Global Oncology Generic Injectable Drugs Revenue by Region
2.5.1 Global Oncology Generic Injectable Drugs Revenue by Region (2017-2022)
2.5.2 Global Oncology Generic Injectable Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology Generic Injectable Drugs Sales by Manufacturers
3.1.1 Global Top Oncology Generic Injectable Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology Generic Injectable Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Generic Injectable Drugs in 2021
3.2 Global Oncology Generic Injectable Drugs Revenue by Manufacturers
3.2.1 Global Oncology Generic Injectable Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology Generic Injectable Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Generic Injectable Drugs Revenue in 2021
3.3 Global Oncology Generic Injectable Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology Generic Injectable Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Generic Injectable Drugs Sales by Type
4.1.1 Global Oncology Generic Injectable Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Oncology Generic Injectable Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology Generic Injectable Drugs Sales Market Share by Type (2017-2028)
4.2 Global Oncology Generic Injectable Drugs Revenue by Type
4.2.1 Global Oncology Generic Injectable Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology Generic Injectable Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Oncology Generic Injectable Drugs Price by Type
4.3.1 Global Oncology Generic Injectable Drugs Price by Type (2017-2022)
4.3.2 Global Oncology Generic Injectable Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology Generic Injectable Drugs Sales by Application
5.1.1 Global Oncology Generic Injectable Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Oncology Generic Injectable Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
5.2 Global Oncology Generic Injectable Drugs Revenue by Application
5.2.1 Global Oncology Generic Injectable Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology Generic Injectable Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Oncology Generic Injectable Drugs Price by Application
5.3.1 Global Oncology Generic Injectable Drugs Price by Application (2017-2022)
5.3.2 Global Oncology Generic Injectable Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology Generic Injectable Drugs Market Size by Type
6.1.1 North America Oncology Generic Injectable Drugs Sales by Type (2017-2028)
6.1.2 North America Oncology Generic Injectable Drugs Revenue by Type (2017-2028)
6.2 North America Oncology Generic Injectable Drugs Market Size by Application
6.2.1 North America Oncology Generic Injectable Drugs Sales by Application (2017-2028)
6.2.2 North America Oncology Generic Injectable Drugs Revenue by Application (2017-2028)
6.3 North America Oncology Generic Injectable Drugs Market Size by Country
6.3.1 North America Oncology Generic Injectable Drugs Sales by Country (2017-2028)
6.3.2 North America Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oncology Generic Injectable Drugs Market Size by Type
7.1.1 Europe Oncology Generic Injectable Drugs Sales by Type (2017-2028)
7.1.2 Europe Oncology Generic Injectable Drugs Revenue by Type (2017-2028)
7.2 Europe Oncology Generic Injectable Drugs Market Size by Application
7.2.1 Europe Oncology Generic Injectable Drugs Sales by Application (2017-2028)
7.2.2 Europe Oncology Generic Injectable Drugs Revenue by Application (2017-2028)
7.3 Europe Oncology Generic Injectable Drugs Market Size by Country
7.3.1 Europe Oncology Generic Injectable Drugs Sales by Country (2017-2028)
7.3.2 Europe Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology Generic Injectable Drugs Market Size by Type
8.1.1 Asia Pacific Oncology Generic Injectable Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology Generic Injectable Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology Generic Injectable Drugs Market Size by Application
8.2.1 Asia Pacific Oncology Generic Injectable Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology Generic Injectable Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology Generic Injectable Drugs Market Size by Region
8.3.1 Asia Pacific Oncology Generic Injectable Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology Generic Injectable Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oncology Generic Injectable Drugs Market Size by Type
9.1.1 Latin America Oncology Generic Injectable Drugs Sales by Type (2017-2028)
9.1.2 Latin America Oncology Generic Injectable Drugs Revenue by Type (2017-2028)
9.2 Latin America Oncology Generic Injectable Drugs Market Size by Application
9.2.1 Latin America Oncology Generic Injectable Drugs Sales by Application (2017-2028)
9.2.2 Latin America Oncology Generic Injectable Drugs Revenue by Application (2017-2028)
9.3 Latin America Oncology Generic Injectable Drugs Market Size by Country
9.3.1 Latin America Oncology Generic Injectable Drugs Sales by Country (2017-2028)
9.3.2 Latin America Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology Generic Injectable Drugs Market Size by Type
10.1.1 Middle East and Africa Oncology Generic Injectable Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology Generic Injectable Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology Generic Injectable Drugs Market Size by Application
10.2.1 Middle East and Africa Oncology Generic Injectable Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology Generic Injectable Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology Generic Injectable Drugs Market Size by Country
10.3.1 Middle East and Africa Oncology Generic Injectable Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Corporation Information
11.1.2 Teva Pharmaceutical Overview
11.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Natco Pharma
11.9.1 Natco Pharma Corporation Information
11.9.2 Natco Pharma Overview
11.9.3 Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Natco Pharma Oncology Generic Injectable Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Natco Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Generic Injectable Drugs Industry Chain Analysis
12.2 Oncology Generic Injectable Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Generic Injectable Drugs Production Mode & Process
12.4 Oncology Generic Injectable Drugs Sales and Marketing
12.4.1 Oncology Generic Injectable Drugs Sales Channels
12.4.2 Oncology Generic Injectable Drugs Distributors
12.5 Oncology Generic Injectable Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology Generic Injectable Drugs Industry Trends
13.2 Oncology Generic Injectable Drugs Market Drivers
13.3 Oncology Generic Injectable Drugs Market Challenges
13.4 Oncology Generic Injectable Drugs Market Restraints
14 Key Findings in The Global Oncology Generic Injectable Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer